Related Experiment Videos
The HPA axis in cocaine use: implications for pharmacotherapy
1Cincinnati Addiction Research Center, OH 45220, USA. winhusen@mdru.uc.edu
Journal of Addictive Diseases
|October 30, 2001
Summary
This review explores the hypothalamic-pituitary-adrenal (HPA) axis in cocaine addiction. HPA-axis-suppressing drugs may help reduce relapse by increasing stress resistance, not fully blocking cocaine
Area of Science:
- Neuroendocrinology
- Addiction Medicine
- Pharmacology
Background:
- The hypothalamic-pituitary-adrenal (HPA) axis plays a crucial role in the stress response and is implicated in substance use disorders.
- Cocaine addiction is characterized by compulsive drug seeking and a high risk of relapse, often triggered by stress.
Purpose of the Study:
- To review the involvement of the HPA axis in cocaine use.
- To evaluate pharmacological treatment strategies targeting the HPA axis for cocaine addiction.
- To assess the potential of HPA-axis-modulating medications in reducing cocaine's reinforcing effects and stress-induced relapse.
Main Methods:
- Literature review of studies investigating the HPA axis in the context of cocaine use and addiction.
- Analysis of two primary treatment approaches: reducing cocaine reinforcement and mitigating stress-induced relapse.
- Discussion of implications for designing clinical trials.
Main Results:
- HPA-axis-suppressing medications are unlikely to completely abolish the reinforcing effects of cocaine.
- These medications may prove beneficial in reducing the frequency of cocaine use.
- A key potential benefit is enhancing an individual's resistance to stress-induced relapse.
Conclusions:
- Pharmacological agents targeting the HPA axis offer a promising avenue for addiction treatment.
- Focusing on increasing stress resilience may be a more viable strategy than solely blocking reinforcement.
- Further inpatient studies are needed to establish the safety and efficacy of candidate HPA-axis-modulating drugs.